Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Adma Biologics

Adma Biologics reported $56.91M in Sales Revenues for its fiscal quarter ending in March of 2023.

Sales Change
Adamis Pharmaceuticals ADMP:US USD 1.45M 697.68K
Adma Biologics ADMA:US USD 56.91M 6.93M
Agile Therapeutics AGRX:US USD 3.81M 183K
Alnylam Pharmaceuticals ALNY:US USD 319.29M 15.74M
BioCryst Pharmaceuticals BCRX:US USD 68.78M 10.77M
Dynavax Technologies DVAX:US USD 46.92M 137.57M
Novavax NVAX:US USD 80.95M 276.45M
Takeda 4502:JP JPY 956.16B 140.4B